Overcoming barriers to advanced biomolecular technologies that inform treatment of solid tumors: a roadmap to access.

Clicks: 107
ID: 283183
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #4 of 4 articles by views in Future oncology (London, England)

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The advent of advanced biomolecular technologies for detecting molecular and genomic signatures of individual tumors has transformed oncology care, introducing proven methodologies that can inform treatment with matched targeted therapies and predict response at the individual patient level. However, access to these technologies has been hampered by multiple barriers, most notably price and obtainability. Other barriers include lack of knowledge of available technologies, concerns about value, and outdated infrastructures that impede critical operations within the clinic or laboratory. Accessibility barriers to advanced biomolecular testing are critically important to patient care, as new technological advances in molecular medicine continue to outpace the implementation of solutions. Given the proven evidence for improved patient outcomes with precision oncology medicines, it is imperative to understand the value afforded by these technologies. The purpose of this narrative review is to describe existing and emerging barriers to access and present a "roadmap to access" that will facilitate the urgently needed discussions to identify solutions for improving access. Implementation of these solutions will raise awareness of available technologies and treatments and their prognostic significance, improve evidence collection for demonstration of value, and fortify clinical and laboratory infrastructure and operations.
Reference Key
garcia-foncillas2025overcoming Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Garcia-Foncillas, Jesús; Bayle, Arnaud; Arnold, Dirk; Avouac, Bernard; Awada, Ahmad; de la Cruz-Merino, Luis; Helland, Åslaug; Lassen, Ulrik; Laurent-Puig, Pierre; Normanno, Nicola; Rohrberg, Kristoffer; Taieb, Julien; Stenzinger, Albrecht
Journal Future oncology (London, England)
Year 2025
DOI
10.1080/14796694.2025.2501523
URL
Keywords
access value biomarkers diagnostics barriers prognostic precision oncology biomolecular technology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.